High Point Advisor Group LLC Fortress Biotech, Inc. Transaction History

High Point Advisor Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.26 - $1.96 $2,590 - $4,029	-2,056 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$1.43 - $1.94 $29,366 - $39,839	-20,536 Reduced 90.9%	2,056 $101,000
Q1 2019 May 08, 2019	SELL	$0.94 - $2.47 $11,127 - $29,239	-11,838 Reduced 34.38%	22,592 $258,000
Q4 2018 Feb 20, 2019	BUY	$0.57 - $1.53 $168 - $451	295 Added 0.86%	34,430 $316,000
Q3 2018 Oct 24, 2018	BUY	$1.44 - $3.13 $17,665 - $38,398	12,268 Added 56.1%	34,135 $274,000

Q2 2018 Aug 20, 2018	BUY	$2.92 - $5.1 $262 - $458	90 Added 0.41%	21,867 $301,000
Q1 2018 Jun 11, 2018	SELL	$3.42 - $5.35 $39,237 - $61,380	-11,473 Reduced 34.51%	21,777 $393,000
Q4 2017 Feb 15, 2018	BUY	$3.26 - $4.84 $108,395 - $160,930	33,250	33,250 $416,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $189M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.